Skip to content
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Red Light Holland Reports Second Quarter 2021 Results

Red Light Holland Reports Second Quarter 2021 Results

  • Post published:November 29, 2021
  • Post category:Press Release
Read more about the article Wesana Health Reports Q3 2021 Financial Results

Wesana Health Reports Q3 2021 Financial Results

  • Post published:November 29, 2021
  • Post category:Press Release
Read more about the article Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans

Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans

  • Post published:November 29, 2021
  • Post category:Press Release
Read more about the article Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing

  • Post published:November 29, 2021
  • Post category:Press Release
Read more about the article atai Life Sciences Increases its Ownership Position in COMPASS Pathways

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

  • Post published:November 29, 2021
  • Post category:Press Release
Read more about the article Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

Numinus Receives Conditional Approval to Graduate to the Toronto Stock Exchange

  • Post published:November 26, 2021
  • Post category:Press Release
Read more about the article Numinus Announces Departure of Stacey Wallin

Numinus Announces Departure of Stacey Wallin

  • Post published:November 25, 2021
  • Post category:Press Release

Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note

  • Post published:November 24, 2021
  • Post category:Press Release
Read more about the article PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus

  • Post published:November 24, 2021
  • Post category:Press Release
Read more about the article Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs

Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs

  • Post published:November 24, 2021
  • Post category:Press Release

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More